Carfilzomib versus Rituximab for Treatment of De Novo Donor Specific Antibodies in Lung Transplant Recipients

被引：0
|
作者：
Razia, D. [1 ]
Hu, C. [2 ]
Cherrier, L. [3 ]
Nasar, A. [3 ]
Walia, R. [1 ]
Tokman, S. [1 ]
机构：
[1] St Josephs Hosp, Norton Thorac Inst, Phoenix, AZ USA
[2] Univ Arizona, Tucson, AZ USA
[3] St Josephs Hosp, Phoenix, AZ USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2022年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
241
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [31] Association between Respiratory Virus Infections and the Development of De Novo HLA Donor-Specific Antibodies in Lung Transplant Recipients.
    Ali, M. I.
    Hata, J.
    Mallea, J.
    Elrefaei, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 483 - 483
  • [32] De Novo Donor Specific Antibody Expression in Lung Transplant Recipients with EVLP-Conditioned Allografts
    Trindade, A. J.
    Stokes, J. W.
    Gannon, W. D.
    Chapin, K. C.
    Lambright, E. S.
    McPherson, K. A.
    Norfolk, S. G.
    Robbins, I. M.
    Shaver, C. M.
    Bacchetta, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S288 - S289
  • [33] LONG-TERM OUTCOMES OF RENAL TRANSPLANT RECIPIENTS TREATED WITH IVIG FOR DE NOVO DONOR SPECIFIC ANTIBODIES
    Knight, Richard J.
    Khan, Naja A.
    Nguyen, Duc T.
    Graviss, Edward A.
    Eagar, Todd N.
    Gaber, Osama
    TRANSPLANTATION, 2020, 104 (09) : S364 - S364
  • [34] Incidence of De Novo Donor Specific Antibodies After Early Steroid Withdrawal in Kidney Transplant Recipients.
    Majmundar, D.
    Karhadkar, S.
    Diamond, A.
    Au, J.
    Ruggia-Check, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 803 - 803
  • [35] Prevalence and Risk Factors for De Novo HLA Donor-Specific Antibodies in Adult Heart Transplant Recipients
    Goldraich, L. A.
    Alba, A. C.
    Ross, H. J.
    Tinckam, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S291 - S292
  • [36] Correlation of histology and de novo donor specific antibodies at time of allograft dysfunction in paediatric renal transplant recipients
    Stojanovic, Jelena
    Jones, Helen E.
    Walsh, Grainne
    Vaughan, Robert
    Taylor, Judy
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1520 - 1520
  • [37] De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
    Kaneku, H.
    O'Leary, J. G.
    Banuelos, N.
    Jennings, L. W.
    Susskind, B. M.
    Klintmalm, G. B.
    Terasaki, P. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (06) : 1541 - 1548
  • [38] Association of CXCR5 Polymorphisms with Detection of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Ono, K.
    Ide, K.
    Nakano, R.
    Sakai, H.
    Tanimine, N.
    Tahara, H.
    Ohira, M.
    Tanaka, Y.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S489 - S490
  • [39] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [40] The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
    Xu, D.
    Richards, K.
    Zheng, K.
    Patel, H.
    Cardarelli, F.
    Pena, J. A.
    Aala, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 844 - 844
12345